DE69417248T2 - Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren - Google Patents

Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren

Info

Publication number
DE69417248T2
DE69417248T2 DE69417248T DE69417248T DE69417248T2 DE 69417248 T2 DE69417248 T2 DE 69417248T2 DE 69417248 T DE69417248 T DE 69417248T DE 69417248 T DE69417248 T DE 69417248T DE 69417248 T2 DE69417248 T2 DE 69417248T2
Authority
DE
Germany
Prior art keywords
steroid
delta
unsaturated
lyase inhibitors
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69417248T
Other languages
English (en)
Other versions
DE69417248D1 (de
Inventor
Norton Peet
Joseph Burkhart
Cynthia Gates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69417248D1 publication Critical patent/DE69417248D1/de
Application granted granted Critical
Publication of DE69417248T2 publication Critical patent/DE69417248T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69417248T 1993-10-27 1994-09-29 Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren Expired - Fee Related DE69417248T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14367993A 1993-10-27 1993-10-27
PCT/US1994/011030 WO1995011914A1 (en) 1993-10-27 1994-09-29 Δ16 unsaturated c¿17? heterocyclic steroids useful as steroid c17-20 lyase inhibitors

Publications (2)

Publication Number Publication Date
DE69417248D1 DE69417248D1 (de) 1999-04-22
DE69417248T2 true DE69417248T2 (de) 1999-08-19

Family

ID=22505119

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417248T Expired - Fee Related DE69417248T2 (de) 1993-10-27 1994-09-29 Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren

Country Status (19)

Country Link
US (3) US5677293A (de)
EP (1) EP0724591B1 (de)
JP (1) JPH09511214A (de)
KR (1) KR960705838A (de)
CN (1) CN1046736C (de)
AT (1) ATE177751T1 (de)
AU (2) AU684844B2 (de)
CA (1) CA2173729C (de)
DE (1) DE69417248T2 (de)
DK (1) DK0724591T3 (de)
ES (1) ES2133582T3 (de)
FI (1) FI961792A (de)
GR (1) GR3030263T3 (de)
HU (1) HUT73855A (de)
IL (1) IL111364A0 (de)
NO (1) NO961693D0 (de)
NZ (1) NZ274694A (de)
WO (1) WO1995011914A1 (de)
ZA (1) ZA948310B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1079859B1 (de) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunktionelle moleküle sowie darauf basierende therapien.
AU6087700A (en) * 1999-07-15 2001-02-05 Procter & Gamble Company, The Nitrogen-containing steroid compounds and their use to regulate hair growth
EP2147679B1 (de) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Zusammensetzungen für den Blut-Hirn-Schrankentransport
US6562457B1 (en) 2001-10-31 2003-05-13 E. I. Du Pont De Nemours And Company Polyether ester elastomer comprising polytrimethylene ether ester soft segment and tetramethylene ester hard segment
US8569275B2 (en) 2002-08-28 2013-10-29 Harbor Therapeutics, Inc. Steroids having 7-oxgen and 17-heteroaryl substitution
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
WO2011088160A2 (en) * 2010-01-15 2011-07-21 Biomarin Pharmaceutical Inc. Novel cyp17 inhibitors
CA2807149C (en) 2010-08-04 2017-05-02 Pellficure Pharmaceuticals, Inc. Novel treatment of prostate carcinoma
CN102746358B (zh) * 2011-04-22 2016-02-10 天津金耀集团有限公司 一种合成孕甾21位溴化物的工艺
CN102898495B (zh) * 2012-11-12 2014-11-26 浙江神洲药业有限公司 醋酸阿比特龙酯的制备方法
CN103059091B (zh) * 2012-11-22 2017-04-19 常州靶点医药科技有限公司 一种避免重金属残留的醋酸阿比特龙的制备方法
CA2902335C (en) 2013-03-14 2021-09-14 Pellficure Pharmaceuticals, Inc. Novel therapy for prostate carcinoma
EP3191087A1 (de) 2014-09-12 2017-07-19 Pellficure Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur behandlung von prostatakrebs
HUP1500055A1 (hu) 2015-02-09 2016-08-29 Druggability Technologies Ip Holdco Ltd Abirateron acetát komplexei, eljárás elõállításukra, és az azokat tartalmazó gyógyászati készítmények
EP3528799A1 (de) 2016-10-24 2019-08-28 Pellficure Pharmaceuticals, Inc. Pharmazeutische zusammensetzungen aus 5-hydroxy-2-methylnaphthalen-1,4-dion
CN106866773A (zh) * 2017-02-14 2017-06-20 西北农林科技大学 一组具有抗癌活性吡唑基甾体衍生物的制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1081647A (en) * 1965-04-01 1967-08-31 Shionogi & Co Furan compounds
AT253975B (de) * 1965-06-15 1967-05-10 Carinthia Elektrogeraete Ges M Trockenrasierapparat
US3436390A (en) * 1966-05-24 1969-04-01 American Home Prod 4,4-dihydroxy-2-butenoic acid lactones
US3398138A (en) * 1966-05-24 1968-08-20 American Home Prod Novel cardenolides and derivatives
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
US4380624A (en) * 1981-07-31 1983-04-19 Advance Biofactures Corp. Novel isomers of bufalin and resibufogenin and their preparation
US4523917A (en) * 1983-12-27 1985-06-18 Dana Corporation Variable pitch diameter torque sensing pulley assembly
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
DE69327096T2 (de) * 1992-03-31 2000-06-21 Btg Int Ltd 17-substituierte steroide, verwendbar bei behandlung von krebs
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate

Also Published As

Publication number Publication date
ES2133582T3 (es) 1999-09-16
US5977094A (en) 1999-11-02
NO961693L (no) 1996-04-26
ATE177751T1 (de) 1999-04-15
DE69417248D1 (de) 1999-04-22
AU695341B2 (en) 1998-08-13
EP0724591A1 (de) 1996-08-07
GR3030263T3 (en) 1999-08-31
FI961792A0 (fi) 1996-04-26
US5965548A (en) 1999-10-12
DK0724591T3 (da) 1999-09-27
JPH09511214A (ja) 1997-11-11
NO961693D0 (no) 1996-04-26
US5677293A (en) 1997-10-14
EP0724591B1 (de) 1999-03-17
IL111364A0 (en) 1994-12-29
HUT73855A (en) 1996-09-30
ZA948310B (en) 1995-06-14
AU684844B2 (en) 1998-01-08
AU7922394A (en) 1995-05-22
CA2173729A1 (en) 1995-05-04
CN1133596A (zh) 1996-10-16
HU9601113D0 (en) 1996-07-29
FI961792A (fi) 1996-04-26
NZ274694A (en) 1998-01-26
AU3993097A (en) 1998-01-08
CA2173729C (en) 2001-05-15
WO1995011914A1 (en) 1995-05-04
CN1046736C (zh) 1999-11-24
KR960705838A (ko) 1996-11-08

Similar Documents

Publication Publication Date Title
ATE177751T1 (de) Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren
DE69423631D1 (de) Thermit-zusammensetzungen zur verwendung als gaserzeugende körper
MX9703564A (es) Inhibidores de proteasa multicatalitica.
DE69818278D1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
DE3864725D1 (de) C17-20-lyase-inhibitoren.
DE59806541D1 (de) Verwendung von alkoholen als additive für putze und/oder mörtel
FI955642A0 (fi) 4-amino-17beta-(syklopropyylioksi)androst-4-en-3-oni, 4-amino-17beta-(syklopropyliamino)androst-4-en-3-oni ja näitä muistuttavat yhdisteet C17-20-lyaasin ja 5alfa-reduktaasin inhibiittoreina
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
DE69502223T2 (de) Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
NO943765L (no) Aryloksybenzen-herbicidmidler
DE60014048D1 (de) 1,5-anhydro-d-fruktose substituiert mit einer hydrophoben gruppe zur verwendung als antioxidant und/oder emulgator
CA2332652A1 (en) .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors
FI946189A (fi) 5-alfa-reduktaasi-inhibiittoreina käyttökelpoiset 17-alkyyliketonisteroidit
ATE277071T1 (de) Durch 11-beta-aryl-17,17-spirothiolan substituierte steroide
DE60331572D1 (de) Stereospezifische reduktion von sapogen-3-onen
NO944124L (no) 17 yre
DE69020520D1 (de) 2,19-Methylenoxy- und 2,19-methylenthiogebrückte Steroide und ihre Verwendung als Inhibitoren von Aromatase und 19-Hydroxylase.
ATE124952T1 (de) Haloethyl substituierte enzymhemmende steroiden.
GB9808018D0 (en) Soil test
DE59811742D1 (de) Verfahren zur Prozessführung eines Anodenbrennofens
DE69628192D1 (de) Darstellung von esterderivaten von steroiden
DE60204800D1 (de) Bestimmte glycin-derivate als faktor xa inhibitoren zur verwendung in der behandlung von thrombose
ES2062927A1 (es) Antagonistas de los receptores de endotelina y procedimiento para su preparacion.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee